Bronchioloalveolar carcinoma presenting as chronic progressive pulmonary infiltrates in a woman with HIV: A diagnosis worth making

Journal of Thoracic Oncology

Volumn 3, Issue 11, 2008, Pages 1353-1355

  Erickson, Todd M ^a   Koeppe, John R ^a   Miller, York E ^b   Stuart, Rodney W ^a   Camidge, D Ross ^a,c  

^a UNIVERSITY OF COLORADO   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Adenocarcinoma; BAC; Bronchioloalveolar carcinoma; Bronchoalveolar carcinoma; HIV; Human immunodeficiency virus; Lung cancer; Lung carcinoma

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; ERLOTINIB; PROTEIN KINASE INHIBITOR; QUINAZOLINE DERIVATIVE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CHRONIC DISEASE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DRUG ERUPTION; DRUG SENSITIVITY; DRUG TOLERABILITY; DYSPNEA; EXON; FEMALE; GENE MUTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INVASIVE CARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG BIOPSY; LUNG INFILTRATE; LUNG NODULE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; THORAX RADIOGRAPHY; TRANSBRONCHIAL BIOPSY; WEIGHT REDUCTION; DIFFERENTIAL DIAGNOSIS; DRUG ANTAGONISM; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS; INTERSTITIAL LUNG DISEASE; MIDDLE AGED; MUTATION; PATHOGENICITY; PATHOLOGY; PROGNOSIS;

ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HIV; HIV INFECTIONS; HUMANS; LUNG DISEASES, INTERSTITIAL; MIDDLE AGED; MUTATION; PROGNOSIS; PROTEIN KINASE INHIBITORS; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 58949088160     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e31818b1ae1     Document Type: Article

References (10)

1. Herida M, Mary-Krause M, Kaphan R, et al. Incidence of non-AIDS-defining cancers before and during the HAART era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol 2003;21:3447- 3453.
2. Bower M, Powles T, Nelson M, et al. HIV-related lung cancer in the era of highly active retroviral therapy. AIDS 2003;17:371-375.
3. Clifford GM, Polesel J, Rickenbach M, et al. cancer risk in the Swiss HIV cohort study: associations with immunodeficiency, smoking and highly active antiretroviral therapy. J Natl Cancer Inst 2005;97:425- 432.
4. Engels EA, Brock MV, Chen J, et al. Elevated incidence of lung cancer among HIV-infected individuals. J Clin Oncol 2006;24:1383-1388.
5. Cadranel J, Garfield D, Lavole A, et al. Lung cancer in HIV infected patients: facts, questions and challenges. Thorax 2006;61:1000-1008.
6. Hakimian R, Fang H, Thomas L, et al. Lung cancer in HIV-infected patients in the era of highly active antiretroviral therapy. J Thorac Oncol 2007;2:268-272.
7. Schiller JH, Harrington D, Belani CP, et al. Comparison of four chemotherapy regimens for advanced non-small cell lung cancer. N Engl J Med 2002;346:92-98.
8. West HL, Franklin WA, McCoy J, et al. Gefitinib therapy in advanced bronchioloalveolar carcinoma: SWOG 0126. J Clin Oncol 2006;24: 1807-1813.
9. Kris MG, Giaccone G, Davies A, et al. Systemic therapy of bronchi-oloalveolar carcinoma: results of the first IASLC/ASCO consensus conference on bronchioloalveolar carcinoma. J Thorac Oncol 2006;1(Suppl): S32-S36.
10. Engleman JA, Janne PA. Mechanisms of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer. Clin Cancer Res 2008;14:2895-2899.